Board of Directors
Our board of directors consists of business professionals, scientists, and public officials who have the vision to see protons as the future of radiation therapy in cancer treatment.
John Cameron, PhD
Founder, Chairman, President & Director
Dr. Cameron has a long and distinguished career in nuclear physics, medical technology, applications of accelerators, and research and development administration, and is among the pioneers in proton therapy. He played a pivotal role in the development of the Midwest Proton Radiotherapy Institute in Bloomington, Indiana, leading it from initial funding through construction. Dr. Cameron served as professor of physics and director of the Indiana University Cyclotron Facility and has directed major multidisciplinary research and development institutes from 1984 to 2004. He has received more than $200 million in grants and contracts and served on numerous advisory and review boards for U.S. and foreign research agencies. Dr. Cameron was elected Fellow of the American Physical Society in 1987.
Dr. Cameron received his undergraduate degree in 1962 from Queens University, Northern Ireland, with first class honors, and his PhD from the University of California, Los Angeles (UCLA) in 1967.
Steven H. Kapp
Steven Kapp is a limited partner of Maverick Capital, a New York-based private investment partnership. He is responsible for the healthcare investment portfolio at Maverick. Prior to Maverick, he was a general partner of Longwood Partners. Prior to Longwood, Mr. Kapp was an officer in corporate development at Airgas, Inc. He earned a BA in Economics and an MBA from the University of North Carolina at Chapel Hill. Mr. Kapp currently serves on the Board of Children’s Scholarship Fund Philadelphia. He resides in Chestnut Hill with his wife and three children.
John Frick previously served as senior vice president of Public Policy and Strategy at ProCure. Prior to his position as senior vice president, he was an advisor and board member for ProCure. He has extensive experience investing in venture capital, leveraged buyouts and turnaround situations, with particular emphasis on healthcare services and healthcare technology. This experience was through Chisholm Private Capital Partners, Capricorn Investors, the Penn Central Corporation and Arthur Andersen & Co.
Mr. Frick has served on Oklahoma Governor's Science & Technology Council since 2004. Mr. Frick graduated cum laude with a BS from Allegheny College and received a MBA from Stanford Graduate School of Business.